TaurelFinance, decoded
Live
Loading market data…
TTaurel

Nektar Therapeutics stock rises on $90M jury verdict vs Lilly

Investing.com· Investing.com· Sep 25, 2026 · 1:17 PM
Nektar Therapeutics stock rises on $90M jury verdict vs Lilly

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

European shares jump over 1% after Democrats sweep US Congress, Novo Nordisk surges
stocksabout 1 hour ago

European shares jump over 1% after Democrats sweep US Congress, Novo Nordisk surges

Investing.com

Europe to invest €525 million in chip startups to catch up with US and China
stocksabout 1 hour ago

Europe to invest €525 million in chip startups to catch up with US and China

Investing.com

McDonald’s earnings analysis: questions answered and next catalysts
stocksabout 1 hour ago

McDonald’s earnings analysis: questions answered and next catalysts

Investing.com